Related Experiment Video
Updated: Apr 15, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma
Ye Dong1, Jianjun Zou2, San Su2
1The 1st Ward of the Medical Department, Affiliated Cancer Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510095, P.R. China.
Abstract:
Hepatocellular carcinoma (HCC) is the fifth most common cancer type worldwide and the third leading cause of cancer-associated mortality. To date, its pathogenesis has remained poorly understood. Previous studies have demonstrated that deregulated microRNA (miR) participates in hepatocarcinogenesis. In the present study, miR-218 and miR-520a were observed to be downregulated in human HCC cells relative to normal hepatic cells. Overexpression of miR-218 or miR-520a inhibited cell proliferation and induced cell cycle arrest at the G0/G1 phase checkpoint. Furthermore, a dual-luciferase reporter assay identified that E2F2 was a novel direct target of miR-218 but not miR-520a in HCC. In addition, miR-218 and miR-520a were observed to negatively regulate E2F2 mRNA and protein levels. This suggested that miR-218 regulated the expression of E2F2 via directly binding to its 3'-untranslated region, whereas miR-520a affected E2F2 expression indirectly. In conclusion, these results indicated that miR-218 and miR-520a are crucial in the development of HCC via the inhibition of cell proliferation and cycle progression by downregulating E2F2.
Insights
Two microRNAs, miR-218 and miR-520a, are downregulated in hepatocellular carcinoma (HCC). Restoring these microRNAs inhibits HCC cell proliferation and progression by targeting E2F2, suggesting their role in liver cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern with poorly understood pathogenesis.
- MicroRNAs (miRNAs) are implicated in cancer development, including liver cancer.
- Identifying specific miRNAs involved in HCC is crucial for understanding its progression.
Purpose of the Study:
- To investigate the role of miR-218 and miR-520a in hepatocellular carcinoma (HCC).
- To determine the downstream targets and regulatory mechanisms of miR-218 and miR-520a in HCC cells.
- To assess the potential of these miRNAs as therapeutic agents for HCC.
Main Methods:
- Quantitative analysis of miR-218 and miR-520a expression in HCC versus normal liver cells.
- Cell proliferation assays and cell cycle analysis following miRNA overexpression.
- Dual-luciferase reporter assays to identify direct miRNA targets.
- Western blotting and quantitative PCR to assess target gene and protein expression.
Main Results:
- miR-218 and miR-520a were significantly downregulated in human HCC tissues and cells.
- Overexpression of miR-218 or miR-520a suppressed HCC cell proliferation and induced G0/G1 cell cycle arrest.
- E2F2 was identified as a direct target of miR-218, and both miRNAs negatively regulated E2F2 expression.
- miR-218 directly targeted E2F2's 3'-untranslated region, while miR-520a's regulation was indirect.
Conclusions:
- miR-218 and miR-520a play critical roles in suppressing hepatocellular carcinoma development.
- These miRNAs inhibit HCC cell proliferation and cell cycle progression, partly through the downregulation of E2F2.
- Restoring miR-218 and miR-520a levels may represent a potential therapeutic strategy for HCC.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Mitogens and the Cell Cycle

